Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy
Effat Noori,Nader Hashemi,Delsuz Rezaee,Reza Maleki,Forough Shams,Bahram Kazemi,Mojgan Bandepour,Fardin Rahimi
DOI: https://doi.org/10.1016/j.intimp.2024.112020
IF: 5.714
2024-04-13
International Immunopharmacology
Abstract:Celiac disease (CD) is a chronic autoimmune enteropathy and multifactorial disease caused by inappropriate immune responses to gluten in the small intestine. Weight loss, anemia, osteoporosis, arthritis, and hepatitis are among the extraintestinal manifestations of active CD. Currently, a strict lifelong gluten-free diet (GFD) is the only safe, effective, and available treatment. Despite the social burden, high expenses, and challenges of following a GFD, 2 to 5 percent of patients do not demonstrate clinical or pathophysiological improvement. Therefore, we need novel and alternative therapeutic approaches for patients. Innovative approaches encompass a broad spectrum of strategies, including enzymatic degradation of gluten, inhibition of intestinal permeability, modulation of the immune response, inhibition of the transglutaminase 2 (TG2) enzyme, blocking antigen presentation by HLA-DQ2/8, and induction of tolerance. Hence, this review is focused on comprehensive therapeutic strategies ranging from dietary approaches to novel methods such as antigen-based immunotherapy, cell and gene therapy, and the usage of nanoparticles for CD treatment.
pharmacology & pharmacy,immunology